8-K: Cardlytics Q3 2025: Revenue Drops 22%, Adjusted EBITDA Positive

Cardlytics reported a 22% year-over-year revenue decrease to $52.0 million in Q3 2025, alongside a positive Adjusted EBITDA of $3.2 million.

Summary

• Revenue for Q3 2025 was $52.0 million, a 22% decrease year-over-year compared to $67.1 million in Q3 2024.
• Billings (non-GAAP) were $89.2 million, a 20% decrease year-over-year compared to $112.0 million in Q3 2024.
• Adjusted Contribution (non-GAAP) was $30.0 million, a 17% decrease year-over-year compared to $36.4 million in Q3 2024.
• Net Loss was $(72.7) million, or $(1.36) per diluted share, a significant improvement from $(145.2) million, or $(2.90) per diluted share, in Q3 2024.
• Adjusted EBITDA (non-GAAP) turned positive at $3.2 million, compared to $(1.8) million in Q3 2024.
• Adjusted Net Loss (non-GAAP) was $(3.8) million, or $(0.07) per diluted share, an improvement from $(7.5) million, or $(0.15) per diluted share, in Q3 2024.
• Net cash provided by operating activities was $1.8 million, up from $1.4 million in Q3 2024.
• Free Cash Flow (non-GAAP) improved to $(2.7) million, compared to $(3.9) million in Q3 2024.
• Monthly Qualified Users (MQUs) increased by 21% year-over-year to 230.3 million, from 190.2 million in Q3 2024.
• Adjusted Contribution Per User (ACPU) was $0.11, down from $0.16 in Q3 2024.

Sentiment

Score: 4

Explanation: Despite improvements in net loss and Adjusted EBITDA turning positive, the substantial year-over-year declines in revenue, billings, and adjusted contribution, coupled with a negative outlook for Q4 2025 top-line growth, indicate ongoing business challenges. The increase in MQUs is offset by a decrease in ACPU, suggesting monetization difficulties.

Positives

• Net Loss significantly improved by 50% to $(72.7) million from $(145.2) million year-over-year.
• Adjusted EBITDA turned positive at $3.2 million, up from a loss of $(1.8) million in the prior year quarter.
• Adjusted Net Loss improved to $(3.8) million from $(7.5) million year-over-year.
• Net cash provided by operating activities increased to $1.8 million from $1.4 million year-over-year.
• Free Cash Flow improved to $(2.7) million from $(3.9) million year-over-year.
• Monthly Qualified Users (MQUs) increased by 21% year-over-year to 230.3 million, indicating expanded reach.
• Management believes decisive actions taken in Q3 will reset the business, improve financial health, and set a viable path to return to growth.

Negatives

• Revenue decreased by 22% year-over-year to $52.0 million.
• Billings (non-GAAP) decreased by 20% year-over-year to $89.2 million.
• Adjusted Contribution (non-GAAP) decreased by 17% year-over-year to $30.0 million.
• Adjusted Contribution Per User (ACPU) decreased to $0.11 from $0.16, indicating lower monetization per user.
• Fourth quarter 2025 guidance anticipates further year-over-year declines in Billings (26%-17%), Revenue (31%-20%), and Adjusted Contribution (29%-14%).

Risks

• Unfavorable conditions in the global economy, including inflationary pressure or trade protection measures, could impact results.
• Quarterly operating results have fluctuated and may continue to vary.
• Ability to sustain revenue growth and billings is uncertain.
• Substantial dependence on the Cardlytics platform poses a risk.
• Significant reliance on a limited number of financial institution (FI) partners, including JPMorgan Chase, Bank of America, Wells Fargo, and American Express.
• Ability to maintain relationships with key FI partners is critical.
• The amount and timing of marketer budgets are affected by budget cycles, economic conditions, and other factors.
• Ability to generate sufficient revenue to offset contractual commitments to FI partners.
• Challenges in attracting new partners and maintaining relationships with bank processors and digital banking providers.
• Intense competition in the market and the ability to compete successfully with current or future competitors.
• Ability to maintain relationships with marketers.
• Need to adapt to changing market conditions, consumer habits, negotiate fee arrangements, and develop new services and features.
• Other risks detailed in the Risk Factors section of the Form 10-Q filed on November 5, 2025.

Future Outlook

Cardlytics anticipates Q4 2025 Billings to be between $86.0 million and $96.0 million (a year-over-year decrease of 26% to 17%), Revenue between $51.1 million and $59.1 million (a decrease of 31% to 20%), Adjusted Contribution between $29.0 million and $35.0 million (a decrease of 29% to 14%), and Adjusted EBITDA between $0.9 million and $7.9 million (compared to a range of $(5.5) million to $1.5 million in Q4 2024).

Management Comments

• "In Q3, we've taken decisive action that we believe will reset our business, improve our financial health, and set ourselves on a viable path to return to growth."
• "We are moving forward with sharper focus and discipline, prioritizing initiatives that build on our fundamental strengths and where we believe we can win."
• "Our mandate is clear continue to deliver for our partners and advertisers, strengthen what differentiates us, and unlock long-term value for our shareholders."

Industry Context

Cardlytics operates in the commerce media platform space, leveraging first-party purchase data from financial institutions to connect advertisers with consumers. The reported declines in revenue and billings suggest ongoing challenges within this specific segment or the broader digital advertising market, potentially impacted by economic conditions or increased competition. While Monthly Qualified Users (MQUs) grew, the drop in Adjusted Contribution Per User (ACPU) indicates lower monetization efficiency, which could be a trend across the industry or specific to Cardlytics' platform strategy and competitive positioning.

Stakeholder Impact

• Shareholders: Potential for continued share price volatility due to declining revenue and billings, despite some improvements in profitability metrics. The 'reset' strategy aims to unlock long-term value.
• Advertisers: Cardlytics aims to continue delivering for advertisers, suggesting ongoing efforts to provide effective commerce media solutions.
• Partners (Financial Institutions): Cardlytics' mandate includes strengthening relationships with partners, which are crucial for its platform's data and reach.

Next Steps

• Cardlytics will discuss its third quarter 2025 financial results during a live audio webcast on November 5, 2025, at 5:00 PM ET / 2:00 PM PT.
• A recorded replay of the webcast will be available on Cardlytics' website following the completion of the call.

Key Dates

Recommendation

While Cardlytics showed improvements in profitability metrics like Net Loss and Adjusted EBITDA, the core business metrics of Revenue and Billings continue to decline significantly, and the Q4 guidance suggests this trend will persist. The increase in Monthly Qualified Users is a positive for reach, but the decrease in Adjusted Contribution Per User indicates challenges in monetization. The CEO's comments about a 'reset' suggest a strategic pivot, but it's too early to see the tangible benefits on the top line. Investors should hold to observe if the strategic initiatives can reverse the revenue decline and improve ACPU in future quarters before considering further investment.

Keywords

Cardlytics, CDLX, Q3 2025, financial results, earnings, revenue, net loss, adjusted EBITDA, billings, commerce media platform, card-linked offers, financial technology, advertising, marketing, monthly qualified users, ACPU